CYTOVANTAGE 3D
LIVE

Serial Number

50055164

Owner

Cytometric Therapeutics Inc

First Use Date

Jun 16, 2025

Filing Date

Aug 17, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CYTOVANTAGE 3D Trademark

Serial Number: 50055164

CYTOVANTAGE 3D is a trademark filed by Cytometric Therapeutics Inc on August 17, 2026. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Cytometric Therapeutics Inc

33741 Copper Lantern St.
Dana Point, CA 92629

Entity Type: 03

Trademark Details

Filing Date

August 17, 2026

Registration Date

Not Registered

First Use Anywhere

June 16, 2025

First Use in Commerce

June 16, 2025

Goods & Services

Medical research laboratory services; Medical research laboratory services in the field of oncology; Medical research laboratories

Cells for scientific, laboratory or medical research

Medical laboratory analysis services relating to the treatment of persons; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood analysis services for diagnostic purposes provided by medical laboratories; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum analysis being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum analysis services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 17, 2026 MAFR
NEW APPLICATION ENTERED
Aug 17, 2026 NWAP